mdlinx mdlinx

Oncology - Diagnostics/Radiology News & Articles

Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.

On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx
New! >> Find out who is the Smartest Doc in Oncology!

Articles

Latest (6) Full Text Articles (304) Focus on Renal
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

881 Gastroenteropancreatic Neuroendocrine Tumors: Role of Imaging in Diagnosis and Management Radiology, January 7, 2013    Clinical Article

882 Automatic multi-modal MR tissue classification for the assessment of response to bevacizumab in patients with glioblastoma European Journal of Radiology, January 7, 2013    Clinical Article

883 CT-guided 125I brachytherapy for mediastinal metastatic lymph nodes recurrence from esophageal carcinoma: Effectiveness and safety in 16 patients European Journal of Radiology, January 7, 2013    Clinical Article

884 Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: A systematic review and meta-analysis European Journal of Radiology, January 7, 2013    Evidence Based Medicine    Review Article

885 Can additional immunohistochemistry staining replace the surgical excision for the diagnosis of papillary breast lesions classified as benign on 14-gage core needle biopsy? Breast Cancer Research and Treatment, January 7, 2013    Clinical Article

886 Dose reduction in oncological staging multidetector CT: effect of iterative reconstruction British Journal of Radiology, January 4, 2013    Clinical Article

887 Tumor Aggressiveness and Patient Outcome in Cancer of the Pancreas Assessed by Dynamic 18F-FDG PET/CT The Journal of Nuclear Medicine, January 4, 2013    Clinical Article

888 The Prognostic Significance of LIAISON CA15-3 Assay in Primary Breast Cancer Anticancer Research, January 4, 2013    Clinical Article

889 Utility of Mesothelin, L1CAM and Afamin as Biomarkers in Primary Ovarian Cancer Anticancer Research, January 4, 2013    Clinical Article

890 Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer Journal of Medical Imaging and Radiation Oncology, January 4, 2013    Clinical Article

891 Mucinous carcinomas of the breast: Imaging features and potential for misdiagnosis Journal of Medical Imaging and Radiation Oncology, January 4, 2013    Clinical Article

892 Imaging differentiation of pathologic fractures caused by primary and secondary bone tumors European Journal of Radiology, January 4, 2013    Clinical Article

893 Perfusion CT can predict tumoral grading of pancreatic adenocarcinoma European Journal of Radiology, January 4, 2013    Clinical Article

894 Prognostic value of alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization Full Text BMC Cancer, January 4, 2013    Clinical Article

895 Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome Full Text BMC Cancer, January 4, 2013    Clinical Article

896 Prospective Histomorphometric and DXA Evaluation of Bone Remodeling in Imatinib-Treated CML Patients: Evidence for Site-Specific Skeletal Effects Journal of Clinical Endocrinology and Metabolism, January 3, 2013    Clinical Article

897 Prognostic implications of the magnetic resonance imaging appearance in papillary renal cell carcinoma European Radiology, January 3, 2013    Clinical Article

898 Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status European Radiology, January 3, 2013    Clinical Article

899 Neck ultrasonography as preoperative localization of primary hyperparathyroidism with an additional role of detecting thyroid malignancy European Journal of Radiology, January 3, 2013    Clinical Article

900 Sonography of intrathyroid parathyroid adenomas: Are there distinctive features that allow for preoperative identification European Journal of Radiology, January 3, 2013    Clinical Article

50 available pages First Previous 41 42 43 44 45 46 47 48 49 50 Next Last

Clinical Pearls in Oncology

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.

Read the article summary

HCC risk increased in patients with AIDS

As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.

Read the article summary

RAB25 is a prognostic marker for ovarian cancer

As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Oncology Articles

Last month's top read Top Articles of 2012

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Other Topics in Oncology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close